Dayton, OH 的 卵巢癌 臨床試驗
9 項針對 卵巢癌 的研究正在 Dayton（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- 還有 5 項
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
招募中2 期
- Kettering Medical Center /ID# 274365, Kettering · 距離 5 英里
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
招募中3 期
- Miami Valley Hospital South, Centerville · 距離 9 英里
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
招募中3 期
- Miami Valley Hospital South, Dayton
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
招募中3 期
- Miami Valley Hospital South, Centerville · 距離 9 英里
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
招募中3 期
- Kettering Health, Kettering · 距離 5 英里
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
招募中
- Miami Valley Hospital, Dayton
- Miami Valley Hospital North, Dayton
- Miami Valley Hospital South, Centerville · 距離 9 英里
- 還有 2 項
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
招募中2 期
- 304, Centerville · 距離 9 英里
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
招募中3 期
- Miami Valley Hospital South, Centerville · 距離 9 英里
其他城市的 卵巢癌 試驗
- Houston, TX89 項研究
- New York City, NY69 項研究
- Boston, MA61 項研究
- Los Angeles, CA50 項研究
- Nashville, TN49 項研究
- Arlington, VA46 項研究
- Philadelphia, PA44 項研究
- Columbus, OH39 項研究
- St. Louis, MO38 項研究
- Chicago, IL36 項研究
- San Antonio, TX31 項研究
- Cleveland, OH30 項研究
Dayton 的其他研究
- 肺癌14 項研究
- 非小細胞肺癌13 項研究
- 脂肪性肝病8 項研究
- 心臟衰竭8 項研究
- 黑色素瘤7 項研究
- 癌症（所有類型）7 項研究
- 子宮內膜癌7 項研究
- 乳癌7 項研究
- 前列腺癌7 項研究
- 肥胖症7 項研究
- 過重6 項研究
- 潰瘍性結腸炎6 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。